DRD2 and bipolar disorder: Aripiprazole, an atypical antipsychotic that partially agonizes dopamine D2 receptors and serotonin 5-HT1A receptors while antagonizing 5-HT2A receptors, is used for schizophrenia and bipolar disorder (Findling et al., 2008).